Article Details

Legochem Bioscience signs agreement with Glycotope to develop cancer drug

Retrieved on: 2022-07-12 16:00:06

Tags for this article:

Click the tags to see associated articles and topics

Legochem Bioscience signs agreement with Glycotope to develop cancer drug. View article details on hiswai:

Excerpt

Stable bioconjugation. LCB's ADC platform technologies overcome the existing limitations of ADCs by imparting a trinity of improved properties, ...

Article found on: www.labiotech.eu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up